CTRI/2023/05/052216招募中3 期
Parotid sparing adaptive radiotherapy in Head and Neck cancers - a randomized controlled trial - PARITY2
试验速览
- 阶段
- 3 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Pathologically proven squamous cell carcinomas of head and neck including oral cavity, oropharynx, hypopharynx, larynx and nasopharynx.
- •Age between 18 â?? 80 years
- •Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
- •Undergoing radical or adjuvant radiation/chemoradiation and requiring bilateral neck irradiation.
- •One or both parotids are intended to receive at least a dose between 25 â?? 30 Gy in the initial plan.
排除标准
- •Prior surgery of the parotid glands
- •Prior radiation therapy to the head and neck region.
- •Prior cytotoxic chemotherapy
- •Poor candidates for regular post-treatment surveillance.
研究者
相似试验
招募中
不适用
Parotid Sparing Adaptive RadiotherapyCTRI/2017/11/010683Tata Medical Centre
尚未招募
不适用
Optimizing the Radiotherapy plan according to tumor shrinkage in Head and Neck Cancers-A Prilimenary StudyCTRI/2018/01/011637CSIR
已完成
不适用
Radiotherapy of the head without the need of a thermoplastic mask, a clinical feasibility study.NL-OMON44293Dr. Bernard Verbeeten Instituut30
终止
4 期
Improving radiotherapy outcomes with smoking cessation: Feasibility trial in head and neck cancer patientsACTRN12614000876695Dr Benjamin Britton40
尚未招募
不适用
Immune sparing Radiotherapy strategies In head and neck Squamous cell carcinoma (IRIS)head and neck cancer (HNC)head and neck squamous cell carcinoma (HNSCC)10027656NL-OMON56801Erasmus MC, Universitair Medisch Centrum Rotterdam42